İsmail Oğuz Kara

Çukurova University

H指数:13

被引数:484

浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic Value of Pretreatment Modified Glasgow Prognostic Score in Nivolumab-Treated Advanced Non-Small Cell Lung Cancer

Nivolumab治疗晚期非小细胞肺癌中治疗前改良格拉斯哥预后评分的预后价值

Journal of Clinical Medicine

IF2.9

2026-10-010

Is There a Tumor Proportion Score Threshold at Which Tumor-Cell PD-L1 Adds Prognostic Information Beyond the International Prognostic Index in Large B-Cell Lymphoma?

是否存在一个肿瘤比例评分阈值，在该阈值下，肿瘤细胞PD-L1能够为大型B细胞淋巴瘤的国际预后指数提供额外的预后信息？

Diagnostics

IF3.3

2026-09-190

EZH2 Expression and Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Retrospective Cohort Study

EZH2表达及免疫检查点抑制剂治疗非小细胞肺癌患者的临床结局：一项真实世界回顾性队列研究

Journal of Clinical Medicine

IF2.9

2026-09-010

Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI-SAFRADJU-2501)

切除后胆道癌的辅助化疗方案：国家性、比较性、观察性研究（TOG/GI-SAFRADJU-2501）

International Journal of Cancer

IF4.7

2026-08-150

OAAI

Erman Akkus; Mehmet Kayaalp; Müzeyyen Aslı Ergözoğlu; Ilgın Koç Kuş; Doğan Bayram; Bilgeşah Kılıçtaş; Emel Ayvaz Güneyin; Ali Kalem; Haydar Temizyürek; Mehmet Mutlu Çatlı; Mehmet Sinan Akarca; Maral Martin Mıldanoğlu; Görkem Turhan; Mahmut Kara; Hacı Arak; Feyza Arslan Tan; Burak Paçacı; Berkay Yeşilyurt; Orhun Akdoğan; Emine Bihter Çetin; Selahattin Çelik; Fatma Keskin Uzundere; Elif Şahin; Zehra Sadak Öcal; Lamia Şeker Can; Bahadır Köylü; Mehmet Cem Fidan; Esmanur Kaplan Tüzün; Teoman Şakalar; Elif Sertesen Çamöz; Haydar Çağatay Yüksel; Onur Yazdan Balçık; Pınar Peker; Mehmet Yılmaz; Şeymanur Ala Enli; Erdem Kölemen; Sibel Oyucu Orhan; Yakup Düzköprü; Mustafa Ersoy; Tuğba Akın Telli; Mesut Yılmaz; Yusuf İlhan; Atila Yıldırım; Ramazan Coşar; Müslih Ürün; Arif Hakan Önder; Murat Araz; Ertuğrul Bayram; Havva Yeşil Çınkır; Ali Alkan; Mustafa Gürbüz; Nilüfer Avcı; Fatma Paksoy Türköz; İsmail Oğuz Kara; Fatih Köse; İlkay Tuğba Ünek; Ahmet Bilici; Öznur Bal; Şuayib Yalçın; Lorenza Rimassa; Hatime Arzu Yaşar

Impact of Anatomical Localization on Systemic Inflammatory Markers and Immune Checkpoint CD47 in Desmoid Tumors

解剖学定位对侵袭性纤维瘤病系统性炎症标志物和免疫检查点CD47的影响

Journal of Clinical Medicine

IF2.9

2026-05-240

Preoperative Lactate Dehydrogenase-to-Albumin Ratio as a Tumor-Host Biomarker of Early Recurrence and Survival in Resected Pulmonary Neuroendocrine Carcinomas: A Multicenter Observational Cohort Study

术前乳酸脱氢酶-白蛋白比率作为切除后肺神经内分泌癌早期复发和生存的肿瘤-宿主生物标志物：一项多中心观察性队列研究

Medicina-Lithuania

IF2.4

2026-05-130

PRE

Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients

比较固定剂量与体重基础剂量纳武利尤单抗治疗非小细胞肺癌患者的疗效

Scientific Reports

IF3.9

2026-05-080

OAAI

Muhammet Cengiz; Oktay Bozkurt; Ayse Nuransoy Cengiz; Deniz Can Guven; Elif Sahin; Emel Mutlu Ozkan; Mustafa Ersoy; Ezgi Turkoğlu; Sedat Yildirim; Erdem Kolemen; Beyza Unlu; Hayati Arvas; Mehmet Mutlu Kidi; Sedat Biter; Latif Karahan; Mustafa Erman; Ismail Oguz Kara; Meltem Baykara; Pervin Can Sanci; Anıl Karakayali; Umut Kefeli; Devrim Cabuk; Saadettin Kilickap; Teoman Sakalar; Nargiz Majidova; Berrak Mermit Ercek; Muslih Urun; Gözde Agdas; Duygu Bayir; Cengiz Akosman; Erkam Kocaaslan; Havva Yesil Cinkir; Aslihan Ezgi Apaydin Rollas; Mevlude Inanc; Metin Ozkan

免疫相关不良事件作为接受帕博利珠单抗治疗的早期三阴性乳腺癌中病理完全缓解的预测因子

Immunotherapy

IF2.3

2026-04-011

PRE

Guren, Ali Kaan; Demircan, Nazim Can; Gumusay, Ozge; Simsek, Eda Tanrikulu; Kemik, Fatih; Karaoglu, Cagla; Sahin, Taha Koray; Tunbekici, Salih; Akkaya, Kubra; Guliyev, Murad; Gezici, Baris; Gur, Hasibe Bilge; Karakas, Delyadil; Unlu, Ahmet; Altunok, Oguz; Nazli, Ismail; Biter, Sedat; Kaya, Tugba; Yetginoglu, Ozge; Gunes, Tugce Kubra; Seker Can, Lamia; Majidova, Nargiz; Sever, Nadiye; Akkus, Aysun Fatma; Kara, Ismail Oguz; Ozturk, Banu; Deligonul, Adem; Kaplan, Muhammet Ali; Atag, Elif; Hacibekiroglu, Ilhan; Demirci, Nebi Serkan; Biricik, Fatih Selcuk; Guven, Deniz Can; Aksoy, Sercan; Arikan, Rukiye; Sari, Murat; Bayoglu, Ibrahim Vedat; Kostek, Osman

Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group

转移性髓样甲状腺癌中的酪氨酸激酶抑制剂治疗：土耳其肿瘤学组的真实世界数据

Journal of Clinical Medicine

IF2.9

2026-03-190

Yildiz, Sedat; Demir, Hacer; Ozudogru, Talha; Gunenc, Damla; Gokdere, Zeynep Sila; Arvas, Hayati; Urakci, Zuhat; Jeral Evinc, Seda; Alan, Ozkan; Colak, Rumeysa; Yilmaz, Mesut; Asik, Esra; Yildirim, Atila; Guren, Ali Kaan; Kostek, Osman; Karabuga, Berkan; Ates, Ozturk; Sencan, Canberk; Yavuzsen, Tugba; Ipek, Suheda Atas; Kara, Ismail Oguz; Sakalar, Teoman; Gokay, Ahmet Cebeli; Yesil Cinkir, Havva; Disli, Ahmet Kursad; Inanc, Mevlude; Unal, Olcun Umit; Yilmaz, Emre; Hacibekiroglu, Ilhan; Kitapli, Sait; Tanriverdi, Ozgur; Sahin, Elif; Sagiroglu, Muhammed Fatih; Yumustutan, Pembegul; Saray, Seray; Celik, Selahattin; Sahinli, Hayriye; Gokmen, Azer; Kahveci, Gizem Bakir; Divriklioglu, Didem; Kilickap, Saadettin

Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter Study

免疫检查点抑制剂在错配修复缺陷型结直肠癌患者中的疗效、安全性和生存结局：一项回顾性、多中心研究

Journal of Clinical Medicine

IF2.9

2026-02-270

OAAI

与健康相关的生活质量和免疫检查点抑制剂治疗长期存活者的心理社会结局：一项全国性多中心研究

Frontiers in Immunology

IF5.9

2025-12-100

Taha Koray Sahin; Fatih Atalah; Bahadir Koylu; Ahmet Oruc; Aydin Acarbay; Akgun Karakok; Sevgi Dogan; Cevat Ilteris Kikili; Görkem Turhan; Gamze Emin; Selahattin Celik; Ilknur Deliktas Onur; Tuba Ugur Tuzcu; Sedat Biter; Safa Can Efil; Fadime Sinem Ardic; Azer Gokmen; Halil Goksel Guzel; Kadri Turan; Ahmet Kürsad Disli; Salih Tunbekici; Erdem Goker; Mevlude Inanc; Ozlem Ozdemir; Banu Ozturk; Muslih Urun; Hatime Arzu Yasar; Mehmet Ali Nahit Sendur; Ismail Oguz Kara; Osman Sutcuoglu; Ozturk Ates; Tulay Eren; Atila Yildirim; Saadettin Kilickap; Omer Dizdar; Fatma Alev Turker; Mustafa Erman; Mehmet Artac; Fatih Selcukbiricik; Sercan Aksoy; Deniz Can Guven

Evaluation of the Meet-URO Score in a Real-World Cohort of mRCC Patients Treated with First-Line TKIs

评估Meet-URO评分在真实世界接受一线TKIs治疗的mRCC患者队列中的应用

Journal of Clinical Medicine 2025, Vol. 14, Page 6385

IF0

2025-09-110

Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group

卡博替尼与舒尼替尼在晚期非透明细胞肾细胞癌中的真实世界比较：土耳其肿瘤学集团的多中心研究

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2025-09-010

PRE

Sahin, Gokhan; Tuzun, Esmanur Kaplan; Guzel, Halil G.; Guliyev, Murad; Disli, Ahmet K.; Yazici, Melike; Yildiz, Oguzhan; Gunes, Tugce K.; Alkan, Suleyman; Kahraman, Emir G.; Ozel, Gamze Serin; Icli, Mehmet C.; Sahin, Elif; Muglu, Harun; Acar, Caner; Tunbekici, Salih; Yuksel, Haydar C.; Yucel, Hakan; Kahya, Burcu Ulas; Kitapli, Sait; Buyuksimsek, Mahmut; Ipek, Suheda A.; Dama, Pinar E.; Usta, Ekin Akyildiz; Yilmaz, Mesut; Asik, Esra; Ozalp, Faruk R.; Savsar, Mehmet G.; Kocaaslan, Erkam; Sim, Saadet; Agaoglu, Ahmet B.; Camoz, Elif Sertesen; Demir, Teyfik; Uyar, Galip C.; Yildirim, Atila; Cinkir, Havva Y.; Salim, Derya Kivrak; Dogu, Gamze Gokoz; Alan, Ozkan; Bayram, Ertugrul; Karacin, Cengiz; Guc, Zeynep G.; Ekinci, Ferhat; Eryilmaz, Melek Karakurt; Semiz, Huseyin S.; Unal, Olcun U.; Goksu, Sema Sezgin; Ozturk, Banu; Inanc, Mevlude; Uygun, Kazim; Hacibekiroglu, Ilhan; Ercolak, Vehbi; Kara, Ismail O.; Yazici, Ozan; Bilici, Ahmet; Tanriverdi, Ozgur; Karaca, Burcak; Erman, Mustafa; Gokmen, Erhan; Goker, Erdem; Yildirim, Hasan Cagri

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study

黑色素瘤的辅助和一线转移治疗的预后因素和结果土耳其肿瘤学组研究

SCIENTIFIC REPORTS

IF3.9

2025-01-250

OAAI

Majidova, Nargiz; Arak, Haci; Ozalp, Faruk Recep; Bas, Onur; Koker, Gulhan Ozcelik; Ozmarasali, Erkan Buket; Karateke, Yasemin Sagdic; Sakalar, Teoman; Yaslikaya, Sendag; Onur, Ilknur Deliktas; Akdag, Goncagul; Ogul, Ali; Guliyev, Murad; Sahin, Elif; Delipoyraz, Ebru Engin; Alkan, Ali; Aydin, Okan; Ilhan, Nurullah; Alan, Ozkan; Akbas, Sinem; Caglar, Yaprak; Guren, Ali Kaan; Sever, Nadiye; Ellez, Halil Ibrahim; Selcukbiricik, Fatih; Atci, Mustafa Muhammed; Bilici, Ahmet; Demirci, Nebi Serkan; Basoglu, Tugba; Karacin, Cengiz; Kara, Ismail Oguz; Yildiz, Bulent; Evrensel, Turkkan; Karaca, Mustafa; Dizdar, Omer; Atag, Elif; Ozgun, Alpaslan; Kostek, Osman

Can the Pathological Response in Patients with Locally Advanced Gastric Cancer Receiving Neoadjuvant Treatment Be Predicted by the CEA/Albumin and CRP/Albumin Ratios?

JOURNAL OF CLINICAL MEDICINE

IF2.9

2024-05-190

OAAI

Exploring the Impact of Cytogenetic Abnormalities on Treatment Responses and Survival Outcomes in Multiple Myeloma: A Single-Centre Experience of 13 Years of Follow-Up

BIOMEDICINES

IF3.9

2024-05-040

OAAI

An open-label trial to assess the safety of regorafenib in Turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)

ANNALS OF ONCOLOGY